{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:22:13Z","timestamp":1750537333557},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We report the case of a 23-year-old man with nodal EMH (extramedullary hematopoiesis) occurring during treatment for a stage IIA \u201cgray-zone\u201d lymphoma. Although it is often related to myeloproliferative bone marrow disease, benign etiologies such as lenograstim treatment after chemotherapy can also induce EMH and be responsible for false-positive <jats:sup>18<\/jats:sup>F-FDG PET\/CT examinations. In this respect, GLUT overexpression in hematopoietic lineages and macrophages of the inflammatory environment are responsible for increased <jats:sup>18<\/jats:sup>F-FDG uptake. Histopathologic confirmation of new hypermetabolic lesions on follow-up PET\/CT may be required when the new lesions do not conform with the treatment responses in the preexisting lesions.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003111","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T21:20:03Z","timestamp":1601500803000},"page":"e373-e375","source":"Crossref","is-referenced-by-count":2,"title":["Lenograstim-Induced Nodal Extramedullary Hematopoiesis"],"prefix":"10.1097","volume":"45","author":[{"given":"Benjamin","family":"Leroy-Freschini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Nicolae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurore","family":"Iltis-Roux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"key":"bib1-20230928","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4065\/78.10.1223","article-title":"Non hepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment","volume":"78","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"bib2-20230928","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41408-018-0156-6","article-title":"Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patients","volume":"8","year":"2018","journal-title":"Blood Cancer J"},{"key":"bib3-20230928","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2147\/CMAR.S161746","article-title":"Extramedullary hematopoiesis secondary to malignant solid tumors: a case report and literature review","volume":"10","year":"2018","journal-title":"Cancer Manag Res"},{"key":"bib4-20230928","first-page":"1014","article-title":"Extramedullary hematopoiesis during therapy with granulocyte colony-stimulating factor","volume":"118","year":"1994","journal-title":"Arch Pathol Lab Med"},{"key":"bib5-20230928","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.semnuclmed.2017.02.006","article-title":"PET in benign bone marrow disorders","volume":"47","year":"2017","journal-title":"Semin Nucl Med"},{"key":"bib6-20230928","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00003072-199905000-00004","article-title":"Fluorine-18 fluorodeoxyglucose splenic uptake from extramedullary hematopoiesis after granulocyte colony-stimulating factor stimulation","volume":"24","year":"1999","journal-title":"Clin Nucl Med"},{"key":"bib7-20230928","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1097\/RLU.0000000000001998","article-title":"False-positive 18F-FDG PET\/CT due to filgrastim that induced extramedullary liver hematopoiesis in a Burkitt lymphoma","volume":"43","year":"2018","journal-title":"Clin Nucl Med"},{"key":"bib8-20230928","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000493752","article-title":"Extramedullary haematopoiesis in axillary lymph nodes of breast carcinoma patients receiving neoadjuvant chemotherapy: a potential diagnostic pitfall","volume":"86","year":"2019","journal-title":"Pathobiology"},{"key":"bib9-20230928","first-page":"bcr201300894","article-title":"Extramedullary hematopoiesis in axillary lymph nodes following neoadjuvant chemotherapy for locally advanced breast cancer","volume":"2013","year":"2013","journal-title":"BMJ Case Rep"},{"key":"bib10-20230928","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1042\/bj3270369","article-title":"Acute regulation of glucose transport in a monocyte-macrophage cell line: Glut-3 affinity for glucose is enhanced during the respiratory burst","volume":"327","year":"1997","journal-title":"Biochem J"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T03:31:43Z","timestamp":1695871903000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003111"}},"subtitle":["A Challenging Diagnosis in Lymphoma Evaluation With 18F-FDG PET\/CT"],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003111","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,18]]}}}